Metabolon, Inc. North Carolina

Metabolon Expands Inflammation Portfolio with Targeted Panels for Cannabinoids, Sphingolipids, and Lipid Mediators of Inflammation

View original content:https://www.prnewswire.co.uk/news-releases/metabolon-expands-inflammation-portfolio-with-targeted-panels-for-cannabinoids-sphingolipids-and-lipid-mediators-of-inflammation-301723354.html